These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24920554)

  • 21. Effect of CXCR4 and CD133 co-expression on the prognosis of patients with stage II~III colon cancer.
    Li XF; Guo XG; Yang YY; Liu AY
    Asian Pac J Cancer Prev; 2015; 16(3):1073-6. PubMed ID: 25735334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
    Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
    Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
    Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
    Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
    Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
    Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma.
    Costa WH; Rocha RM; Cunha IW; Fonseca FP; Guimaraes GC; Zequi Sde C
    World J Urol; 2012 Aug; 30(4):553-8. PubMed ID: 21969131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
    Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
    Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of S100A4 in human pancreatic cancer is associated with invasion.
    Tsukamoto N; Egawa S; Akada M; Abe K; Saiki Y; Kaneko N; Yokoyama S; Shima K; Yamamura A; Motoi F; Abe H; Hayashi H; Ishida K; Moriya T; Tabata T; Kondo E; Kanai N; Gu Z; Sunamura M; Unno M; Horii A
    Pancreas; 2013 Aug; 42(6):1027-33. PubMed ID: 23851436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer.
    Maeda S; Shinchi H; Kurahara H; Mataki Y; Maemura K; Sato M; Natsugoe S; Aikou T; Takao S
    Br J Cancer; 2008 Apr; 98(8):1389-97. PubMed ID: 18349830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
    Chan AW; Tong JH; Chan SL; Lai PB; To KF
    Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.
    Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y
    Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis.
    Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A
    J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with E-cadherin expression].
    Lu G; Wu X; Zhou L; Yu L; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1632-7. PubMed ID: 24273267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
    Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
    Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
    Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD133 mRNA expression and microsatellite instability in colorectal carcinoma.
    Huh JW; Park YS; Lee JH; Kim HR; Shin MG; Kim YJ
    J Surg Oncol; 2010 Dec; 102(7):765-70. PubMed ID: 20872808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship of expression of CD44v6 with metastasis and prognosis in breast cancer].
    Deng Y; Ma W; Fang X; Zheng S
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):451-2. PubMed ID: 11832082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis.
    Ding Q; Miyazaki Y; Tsukasa K; Matsubara S; Yoshimitsu M; Takao S
    Mol Cancer; 2014 Jan; 13():15. PubMed ID: 24468059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinoma.
    Kim K; Ro JY; Kim S; Cho YM
    Hum Pathol; 2012 Dec; 43(12):2109-16. PubMed ID: 22944295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.